People · Operator
Named in public records as an officer, director or promoter · active 2016–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chronix Biomedical Inc | — | Biotechnology | Series A | $20.6M | $119.5M | 2016 |
Howard B Urnovitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Howard B Urnovitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Mitchell | 1 | 7 |
| Michael Jerstad | 1 | 4 |
| Robert Leppo | 1 | 2 |
| William B Mitchell | 1 | 2 |
| Paul Freiman | 1 | 2 |
| Michael B Jerstad | 1 | 1 |
| William B Boeger III | 1 | 1 |
| David B MacKenzie | 1 | 1 |
| Ekkehard B Schuetz | 1 | 1 |
| Robert B Leppo | 1 | 1 |
| Paul B Freiman | 1 | 1 |
| William Boeger III | 1 | 1 |
| David MacKenzie | 1 | 1 |
| John DiPietro | 1 | 1 |
| Howard Urnovitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.